-
BioMarin Pharmaceutical Inc. (BMRN $56.70)
- $56.70 P/E (TTM): 21.3X Cap: $11.19B
- View BMRN Profile
- View Questions on BMRN
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Telo Genomics Corp. (TELO)
- P/E (TTM): -21.9X Cap: $2M
- View TELO Profile
- View Questions on TELO
-
Medicenna Therapeutics Corp. (MDNA $0.81)
- $0.81 Cap: $72M
- View MDNA Profile
- View Questions on MDNA
-
BioMarin Pharmaceutical Inc. (BMRN $56.70)
- $56.70 P/E (TTM): 21.3X Cap: $11.19B
- View BMRN Profile
- View Questions on BMRN
-
CRISPR Therapeutics AG (CRSP $66.33)
- $66.33 Cap: $5.62B
- View CRSP Profile
- View Questions on CRSP
-
BriaCell Therapeutics Corp. (BCT $1.10)
- $1.10 Cap: $4M
- View BCT Profile
- View Questions on BCT
-
Guardant Health Inc. (GH $45.67)
- $45.67 Cap: $5.75B
- View GH Profile
- View Questions on GH
-
Twist Bioscience Corporation (TWST $34.70)
- $34.70 Cap: $2.10B
- View TWST Profile
- View Questions on TWST
-
NurExone Biologic Inc. (NRX $0.71)
- $0.71 Cap: $56M
- View NRX Profile
- View Questions on NRX
-
Tempus AI Inc. (TEM $58.83)
- $58.83 Cap: $10.55B
- View TEM Profile
- View Questions on TEM
Q: The best Canadian public genomic stocks to buy now?
The best public genomic stocks in the world to buy now?
Thank you.
The best public genomic stocks in the world to buy now?
Thank you.
-
Gilead Sciences Inc. (GILD $108.80)
- $108.80 P/E (TTM): 22.74X Cap: $134.61B
- View GILD Profile
- View Questions on GILD
-
Illumina Inc. (ILMN $95.47)
- $95.47 Cap: $15.21B
- View ILMN Profile
- View Questions on ILMN
-
Intuitive Surgical Inc. (ISRG $515.93)
- $515.93 P/E (TTM): 75.93X Cap: $185.88B
- View ISRG Profile
- View Questions on ISRG
-
AbbVie Inc. (ABBV $185.26)
- $185.26 P/E (TTM): 80.88X Cap: $334.30B
- View ABBV Profile
- View Questions on ABBV
-
Eli Lilly and Company (LLY $762.36)
- $762.36 P/E (TTM): 62.79X Cap: $731.37B
- View LLY Profile
- View Questions on LLY
-
UnitedHealth Group Incorporated (DE) (UNH $281.70)
- $281.70 P/E (TTM): 11.83X Cap: $256.40B
- View UNH Profile
- View Questions on UNH
-
Novo Nordisk A/S (NVO $64.78)
- $64.78 P/E (TTM): 18.14X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
-
BioMarin Pharmaceutical Inc. (BMRN $56.70)
- $56.70 P/E (TTM): 21.3X Cap: $11.19B
- View BMRN Profile
- View Questions on BMRN
Q: I am working on increasing my sector representation in Healthcare. I will shortly have filled a full position in ISRG, adding in this downturn. I have traded around UNH, and am planning to take it from a 1/2 to full position. I have 1/4 position in ILMN and do not think I should be topping it up; I perceive it to be risky. I need 2 more companies, or may need to take one or both of IRSG/UNH to more than a full position.
This provides me a surgical/instrumentation company and a service/product supplier. For diversity in the Healthcare space can you rank your preferred buys (with entry points) I'd appreciate 2 recommendations on the pharmaseuticals side and 2 on the biotech side, or as you may see that fits better.
While I am open US companies I do have a concern that the Trump administration will bring the DOGE and Executive Order train wrecks to health care. I would appreciate your views on this potential action and howe it may impact investment choice in the field.
Thanks as always,
Dave
This provides me a surgical/instrumentation company and a service/product supplier. For diversity in the Healthcare space can you rank your preferred buys (with entry points) I'd appreciate 2 recommendations on the pharmaseuticals side and 2 on the biotech side, or as you may see that fits better.
While I am open US companies I do have a concern that the Trump administration will bring the DOGE and Executive Order train wrecks to health care. I would appreciate your views on this potential action and howe it may impact investment choice in the field.
Thanks as always,
Dave
-
Amgen Inc. (AMGN $295.40)
- $295.40 P/E (TTM): 26.87X Cap: $158.49B
- View AMGN Profile
- View Questions on AMGN
-
NVIDIA Corporation (NVDA $172.07)
- $172.07 P/E (TTM): 55.62X Cap: $4.20T
- View NVDA Profile
- View Questions on NVDA
-
Regeneron Pharmaceuticals Inc. (REGN $547.72)
- $547.72 P/E (TTM): 13.79X Cap: $58.57B
- View REGN Profile
- View Questions on REGN
-
AbbVie Inc. (ABBV $185.26)
- $185.26 P/E (TTM): 80.88X Cap: $334.30B
- View ABBV Profile
- View Questions on ABBV
-
Cognex Corporation (CGNX $33.80)
- $33.80 P/E (TTM): 50.1X Cap: $5.71B
- View CGNX Profile
- View Questions on CGNX
-
BioMarin Pharmaceutical Inc. (BMRN $56.70)
- $56.70 P/E (TTM): 21.3X Cap: $11.19B
- View BMRN Profile
- View Questions on BMRN
Q: I am considering the above to add to my tfsa, please advise in order which are best suited today or please add your own suggestions. Thanks
Insiders
Share Information
SEC Filings
News and Media